-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on UiPath, Lowers Price Target to $14

Benzinga·09/25/2026 16:06:02
UBS analyst Radi Sultan maintains UiPath (NYSE:PATH) with a Neutral and lowers the price target from $15 to $14.